The landscape of dementia prognosis has evolved substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology a long time just before signs and symptoms arise. When these technological improvements signify remarkable development in knowing neurodegenerative illnesses, https://elizabethq753scp4.theisblog.com/profile